{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:58:46Z","timestamp":1766023126470,"version":"3.48.0"},"reference-count":47,"publisher":"e-Century Publishing Corporation","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Clin Exp Immunol"],"DOI":"10.62347\/bduc7952","type":"journal-article","created":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T05:44:49Z","timestamp":1720503889000},"page":"117-132","source":"Crossref","is-referenced-by-count":0,"title":["Cutaneous manifestations associated with COVID-19 infection at a university hospital in eastern China"],"prefix":"10.62347","volume":"13","author":[{"given":"Lingyi","family":"Lu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"48694","published-online":{"date-parts":[[2024]]},"reference":[{"key":"ref0","unstructured":"Cucinotta D and Vanelli M. WHO declares COVID-19 a pandemic. Acta Biomed 2020; 91: 157-160."},{"key":"ref1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/jocd.15477","article-title":"COVID-19 and cutaneous manifestations: a review of the published literature","volume":"22","author":"Martora","year":"2023","unstructured":"Martora F, Villani A, Fabbrocini G and Battista T. COVID-19 and cutaneous manifestations: a review of the published literature. J Cosmet Dermatol 2023; 22: 4-10.","journal-title":"J Cosmet Dermatol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"634208","DOI":"10.3389\/fmed.2021.634208","article-title":"Skin manifestations in COVID-19 patients: are they indicators for disease severity? A systematic review","volume":"8","author":"Jamshidi","year":"2021","unstructured":"Jamshidi P, Hajikhani B, Mirsaeidi M, Vahidnezhad H, Dadashi M and Nasiri MJ. Skin manifestations in COVID-19 patients: are they indicators for disease severity? A systematic review. Front Med (Lausanne) 2021; 8: 634208.","journal-title":"Front Med (Lausanne)"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"3261","DOI":"10.3390\/jcm9103261","article-title":"Skin manifestations in COVID-19: prevalence and relationship with disease severity","volume":"9","author":"Giavedoni","year":"2020","unstructured":"Giavedoni P, Podlipnik S, Pericàs JM, Fuertes de Vega I, García-Herrera A, Alós L, Carrera C, Andreu-Febrer C, Sanz-Beltran J, Riquelme-Mc Loughlin C, Riera-Monroig J, Combalia A, Bosch-Amate X, Morgado-Carrasco D, Pigem R, Toll-Abelló A, Martí-Martí I, Rizo-Potau D, Serra-García L, Alamon-Reig F, Iranzo P, Almuedo-Riera A, Muñoz J, Puig S and Mascaró JM Jr. Skin manifestations in COVID-19: prevalence and relationship with disease severity. J Clin Med 2020; 9: 3261.","journal-title":"J Clin Med"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Estébanez A, Pérez-Santiago L, Silva E, Guillen-Climent S, García-Vázquez A and Ramón MD. Cutaneous manifestations in COVID-19: a new contribution. J Eur Acad Dermatol Venereol 2020; 34: e250-e251.","DOI":"10.1111\/jdv.16474"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Recalcati S. Cutaneous manifestations in COVID-19: a first perspective. J Eur Acad Dermatol Venereol 2020; 34: e212-e213.","DOI":"10.1111\/jdv.16387"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.ad.2020.08.002","article-title":"Cutaneous manifestations in the context of SARS-CoV-2 infection (COVID-19)","volume":"111","author":"Carrascosa","year":"2020","unstructured":"Carrascosa JM, Morillas V, Bielsa I and Munera-Campos M. Cutaneous manifestations in the context of SARS-CoV-2 infection (COVID-19). Actas Dermosifiliogr (Engl Ed) 2020; 111: 734-742.","journal-title":"Actas Dermosifiliogr (Engl Ed)"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1111\/1346-8138.16672","article-title":"Prevalence of cutaneous manifestations in COVID-19: a meta-analysis","volume":"50","author":"Li","year":"2023","unstructured":"Li J, Wen W, Mu Z, Du X and Han X. Prevalence of cutaneous manifestations in COVID-19: a meta-analysis. J Dermatol 2023; 50: 622-636.","journal-title":"J Dermatol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"WJ","year":"2020","unstructured":"Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY and Zhong NS; China Medical Treatment Expert Group for Covid-19. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020; 382: 1708-20.","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/bjd.19163","article-title":"Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases","volume":"183","author":"Galv&#xE1","year":"2020","unstructured":"Galván Casas C, Català A, Carretero Hernández G, Rodríguez-Jiménez P, Fernández-Nieto D, Rodríguez-Villa Lario A, Navarro Fernández I, Ruiz-Villaverde R, Falkenhain-López D, Llamas Velasco M, García-Gavín J, Baniandrés O, González-Cruz C, Morillas-Lahuerta V, Cubiró X, Figueras Nart I, Selda-Enriquez G, Romaní J, Fustà-Novell X, Melian-Olivera A, Roncero Riesco M, Burgos-Blasco P, Sola Ortigosa J, Feito Rodriguez M and García-Doval I. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol 2020; 183: 71-7.","journal-title":"Br J Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Al Ali A, Al-Shidhani S, Al-Balushi F, Alhinai M, Al-Azri AR, Al Lawati SAL, Al Ghailani F and Al Riyami R. Cutaneous manifestations of COVID-19: an experience from Oman. Cureus 2021; 13: e16667.","DOI":"10.7759\/cureus.16667"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1111\/1346-8138.16651","article-title":"Cutaneous manifestations of COVID-19 and COVID-19 vaccination","volume":"50","author":"Nakashima","year":"2023","unstructured":"Nakashima C, Kato M and Otsuka A. Cutaneous manifestations of COVID-19 and COVID-19 vaccination. J Dermatol 2023; 50: 280-289.","journal-title":"J Dermatol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1080\/23744235.2022.2153913","article-title":"Paraviral cutaneous manifestations associated to SARS-CoV-2 Omicron variant","volume":"55","author":"Zupin","year":"2023","unstructured":"Zupin L, Moltrasio C, Tricarico PM, Del Vecchio C, Fontana F, Marzano AV and Crovella S. Paraviral cutaneous manifestations associated to SARS-CoV-2 Omicron variant. Infect Dis (Lond) 2023; 55: 181-188.","journal-title":"Infect Dis (Lond)"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jaad.2021.03.064","article-title":"Cutaneous manifestations of SARS-CoV-2: a two center, prospective, case-controlled study","volume":"85","author":"Unterluggauer","year":"2021","unstructured":"Unterluggauer L, Pospischil I, Krall C, Saluzzo S, Kimeswenger S, Karolyi M, Wenisch C, Lamprecht B, Guenova E, Winkler S, Viczenczova C, Bergthaler A, Weninger W, Hoetzenecker W and Stary G. Cutaneous manifestations of SARS-CoV-2: a two center, prospective, case-controlled study. J Am Acad Dermatol 2021; 85: 202-4.","journal-title":"J Am Acad Dermatol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"5595016","DOI":"10.1155\/2021\/5595016","article-title":"Patient recovery from COVID-19 infections: follow-up of hair, nail, and cutaneous manifestations","volume":"2021","author":"Thuangtong","year":"2021","unstructured":"Thuangtong R, Angkasekwinai N, Leeyaphan C, Triwongwaranat D, Thanomkitti K, Munprom K and Kulthanan K. Patient recovery from COVID-19 infections: follow-up of hair, nail, and cutaneous manifestations. Biomed Res Int 2021; 2021: 5595016.","journal-title":"Biomed Res Int"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s00403-022-02450-z","article-title":"COVID-19 infection leading to acute pustular dermatoses","volume":"315","author":"Goyal","year":"2023","unstructured":"Goyal PK, Mohammed TO, Mahmoud A, Zaidi AJ and Nguyen CV. COVID-19 infection leading to acute pustular dermatoses. Arch Dermatol Res 2023; 315: 685-697.","journal-title":"Arch Dermatol Res"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Cavanagh G and Wambier CG. Reply to: “Personal protective equipment recommendations based on COVID-19 route of transmission”. J Am Acad Dermatol 2020; 83: e47.","DOI":"10.1016\/j.jaad.2020.04.102"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Gupta MK and Lipner SR. Personal protective equipment recommendations based on COVID-19 route of transmission. J Am Acad Dermatol 2020; 83: e45-e46.","DOI":"10.1016\/j.jaad.2020.04.068"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Dupont L, Duquia RP, Pizutti GW, Nunes FB, Branchini G, Mosquera ESB and Bonamigo RR. Cutaneous manifestations in patients with COVID-19 treated at a University Hospital in Southern Brazil. Cureus 2022; 14: e31566.","DOI":"10.7759\/cureus.31566"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"67","DOI":"10.4103\/idoj.idoj_279_22","article-title":"Cutaneous manifestations associated with COVID-19 infection in a COVID-designated hospital in North Chennai - A descriptive cross-sectional study","volume":"14","author":"Kumar","year":"2022","unstructured":"Kumar P, Radha G, Muthukrishnan M, Chandrasekaran B, Subbiah P and Raman J. Cutaneous manifestations associated with COVID-19 infection in a COVID-designated hospital in North Chennai - A descriptive cross-sectional study. Indian Dermatol Online J 2022; 14: 67-71.","journal-title":"Indian Dermatol Online J"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.abd.2022.03.006","article-title":"Skin, mucosa and nail findings in hospitalized pediatric patients with Coronavirus disease-2019 (COVID-19)","volume":"98","author":"&#xD6","year":"2023","unstructured":"Özen T, Kahraman FC, Öcal S and Ovalı HF. Skin, mucosa and nail findings in hospitalized pediatric patients with Coronavirus disease-2019 (COVID-19). An Bras Dermatol 2023; 98: 208-215.","journal-title":"An Bras Dermatol"},{"key":"ref21","unstructured":"World Health Organization. Living Guidance for Clinical Management of COVID-19. Version 23 November 2021. Available online: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/ 349321\/WHO-2019-nCoV-clinical-2021.2-eng.pdf (accessed on 7 July 2022)."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1056\/NEJMe2009758","article-title":"Asymptomatic transmission, the achilles’ heel of current strategies to control Covid-19","volume":"382","author":"Gandhi","year":"2020","unstructured":"Gandhi M, Yokoe DS and Havlir DV. Asymptomatic transmission, the achilles’ heel of current strategies to control Covid-19. N Engl J Med 2020; 382: 2158-2160.","journal-title":"N Engl J Med"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1056\/NEJMoa2008457","article-title":"Presymptomatic SARS-CoV-2 infections and transmission in a skilled nursing facility","volume":"382","author":"MM","year":"2020","unstructured":"Arons MM, Hatfield KM, Reddy SC, Kimball A, James A, Jacobs JR, Taylor J, Spicer K, Bardossy AC, Oakley LP, Tanwar S, Dyal JW, Harney J, Chisty Z, Bell JM, Methner M, Paul P, Carlson CM, McLaughlin HP, Thornburg N, Tong S, Tamin A, Tao Y, Uehara A, Harcourt J, Clark S, Brostrom-Smith C, Page LC, Kay M, Lewis J, Montgomery P, Stone ND, Clark TA, Honein MA, Duchin JS and Jernigan JA; Public Health-Seattle and King County and CDC COVID-19 Investigation Team. Presymptomatic SARS-CoV-2 infections and transmission in a skilled nursing facility. N Engl J Med 2020; 382: 2081-2090.","journal-title":"N Engl J Med"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/jmv.25776","article-title":"Alert for non-respiratory symptoms of coronavirus disease 2019 (COVID-19) patients in epidemic period: a case report of familial cluster with three asymptomatic COVID-19 patients","volume":"93","author":"Lu","year":"2021","unstructured":"Lu S, Lin J, Zhang Z, Xiao L, Jiang Z, Chen J, Hu C and Luo S. Alert for non-respiratory symptoms of coronavirus disease 2019 (COVID-19) patients in epidemic period: a case report of familial cluster with three asymptomatic COVID-19 patients. J Med Virol 2021; 93: 518-521.","journal-title":"J Med Virol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1016\/S0140-6736(20)30917-X","article-title":"COVID-19: the case for health-care worker screening to prevent hospital transmission","volume":"395","author":"Black","year":"2020","unstructured":"Black JRM, Bailey C, Przewrocka J, Dijkstra KK and Swanton C. COVID-19: the case for health-care worker screening to prevent hospital transmission. Lancet 2020; 395: 1418-1420.","journal-title":"Lancet"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Askin O, Altunkalem RN, Altinisik DD, Uzuncakmak TK, Tursen U and Kutlubay Z. Cutaneous manifestations in hospitalized patients diagnosed as COVID-19. Dermatol Ther 2020; 33: e13896.","DOI":"10.1111\/dth.13896"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jdin.2020.05.004","article-title":"Cutaneous drug eruptions associated with COVID-19 therapy","volume":"1","author":"Atzori","year":"2020","unstructured":"Atzori L, Perla S, Atzori MG, Ferreli C and Rongioletti F. Cutaneous drug eruptions associated with COVID-19 therapy. JAAD Int 2020; 1: 73-76.","journal-title":"JAAD Int"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1111\/ced.14694","article-title":"Periorbital erythema is a common cutaneous manifestation in COVID-19","volume":"46","author":"Terzi","year":"2021","unstructured":"Terzi K, Kesici S, Özsürekci Y and Bayrakci B. Periorbital erythema is a common cutaneous manifestation in COVID-19. Clin Exp Dermatol 2021; 46: 1316-1317.","journal-title":"Clin Exp Dermatol"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Herrero-Moyano M, Capusan TM, Andreu-Barasoain M, Alcántara-González J, Ruano-Del Salado M, Sánchez-Largo Uceda ME, Calzado-Villarreal L and Pérez-González Y. A clinicopathological study of eight patients with COVID-19 pneumonia and a late-onset exanthema. J Eur Acad Dermatol Venereol 2020; 34: e460-e464.","DOI":"10.1111\/jdv.16631"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.jaad.2020.04.161","article-title":"Chilblains is a common cutaneous finding during the COVID-19 pandemic: a retrospective nationwide study from France","volume":"83","author":"Masson A","year":"2020","unstructured":"de Masson A, Bouaziz JD, Sulimovic L, Cassius C, Jachiet M, Ionescu MA, Rybojad M, Bagot M and Duong TA; SNDV (French National Union of Dermatologists-Venereologists). Chilblains is a common cutaneous finding during the COVID-19 pandemic: a retrospective nationwide study from France. J Am Acad Dermatol 2020; 83: 667-670.","journal-title":"J Am Acad Dermatol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jaad.2020.04.044","article-title":"Varicella-like exanthem as a specific COVID-19-associated skin manifestation: multicenter case series of 22 patients","volume":"83","author":"Marzano","year":"2020","unstructured":"Marzano AV, Genovese G, Fabbrocini G, Pigatto P, Monfrecola G, Piraccini BM, Veraldi S, Rubegni P, Cusini M, Caputo V, Rongioletti F, Berti E and Calzavara-Pinton P. Varicella-like exanthem as a specific COVID-19-associated skin manifestation: multicenter case series of 22 patients. J Am Acad Dermatol 2020; 83: 280-285.","journal-title":"J Am Acad Dermatol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1111\/ced.14277","article-title":"Clinical and histological characterization of vesicular COVID-19 rashes: a prospective study in a tertiary care hospital","volume":"45","author":"Fernandez-Nieto","year":"2020","unstructured":"Fernandez-Nieto D, Ortega-Quijano D, Jimenez-Cauhe J, Burgos-Blasco P, de Perosanz-Lobo D, Suarez-Valle A, Cortes-Cuevas JL, Carretero I, Garcia-Del Real C and Fernandez-Guarino M. Clinical and histological characterization of vesicular COVID-19 rashes: a prospective study in a tertiary care hospital. Clin Exp Dermatol 2020; 45: 872-875.","journal-title":"Clin Exp Dermatol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.jaad.2020.05.073","article-title":"Cutaneous manifestations related to coronavirus disease 2019 (COVID-19): a prospective study from China and Italy","volume":"83","author":"De Giorgi","year":"2020","unstructured":"De Giorgi V, Recalcati S, Jia Z, Chong W, Ding R, Deng Y, Scarfi F, Venturi F, Trane L, Gori A, Silvestri F, Gao XH and Lotti T. Cutaneous manifestations related to coronavirus disease 2019 (COVID-19): a prospective study from China and Italy. J Am Acad Dermatol 2020; 83: 674-675.","journal-title":"J Am Acad Dermatol"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"Fernandez-Nieto D, Ortega-Quijano D, Segurado-Miravalles G, Pindado-Ortega C, Prieto-Barrios M and Jimenez-Cauhe J. Comment on: cutaneous manifestations in COVID-19: a first perspective. Safety concerns of clinical images and skin biopsies. J Eur Acad Dermatol Venereol 2020; 34: e252-e254.","DOI":"10.1111\/jdv.16470"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/s00011-020-01370-w","article-title":"Are the cutaneous manifestations during or due to SARS-CoV-2 infection\/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms","volume":"69","author":"Criado","year":"2020","unstructured":"Criado PR, Abdalla BMZ, De Assis IC, Van Blarcum de Graaff Mello C, Caputo GC and Vieira IC. Are the cutaneous manifestations during or due to SARS-CoV-2 infection\/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms. Inflamm Res 2020; 69: 745-756.","journal-title":"Inflamm Res"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"Bhavsar A, Lonnet G, Wang C, Chatzikonstantinidou K, Parikh R, Brabant Y, Servotte N, Shi M, Widenmaier R and Aris E. Increased risk of herpes zoster in adults ≥50 years old diagnosed with COVID-19 in the United States. Open Forum Infect Dis 2022; 9: ofac118.","DOI":"10.1093\/ofid\/ofac118"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/jth.14768","article-title":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia","volume":"18","author":"Tang","year":"2020","unstructured":"Tang N, Li D, Wang X and Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost 2020; 18: 844-847.","journal-title":"J Thromb Haemost"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.jaad.2020.05.109","article-title":"Pernio-like skin lesions associated with COVID-19: a case series of 318 patients from 8 countries","volume":"83","author":"EE","year":"2020","unstructured":"Freeman EE, McMahon DE, Lipoff JB, Rosenbach M, Kovarik C, Takeshita J, French LE, Thiers BH, Hruza GJ and Fox LP; American Academy of Dermatology Ad Hoc Task Force on COVID-19. Pernio-like skin lesions associated with COVID-19: a case series of 318 patients from 8 countries. J Am Acad Dermatol 2020; 83: 486-492.","journal-title":"J Am Acad Dermatol"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.anpede.2020.04.002","article-title":"Cutaneous manifestations in the current pandemic of coronavirus infection disease (COVID 2019)","volume":"92","author":"Morey-Olive","year":"2020","unstructured":"Morey-Olive M, Espiau M, Mercadal-Hally M, Lera-Carballo E and Garcia-Patos V. Cutaneous manifestations in the current pandemic of coronavirus infection disease (COVID 2019). An Pediatr (Engl Ed) 2020; 92: 374-375.","journal-title":"An Pediatr (Engl Ed)"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"Bouaziz JD, Duong TA, Jachiet M, Velter C, Lestang P, Cassius C, Arsouze A, Domergue Than Trong E, Bagot M, Begon E, Sulimovic L and Rybojad M. Vascular skin symptoms in COVID-19: a french observational study. J Eur Acad Dermatol Venereol 2020; 34: e451-e452.","DOI":"10.1111\/jdv.16544"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/ajd.12895","article-title":"A clinical practice narrative","volume":"60","author":"Rademaker","year":"2019","unstructured":"Rademaker M, Agnew K, Anagnostou N, Andrews M, Armour K, Baker C, Foley P, Gebauer K, Gupta M, Marshman G, Rubel D, Sullivan J and Wong LC. Psoriasis and infection. A clinical practice narrative. Australas J Dermatol 2019; 60: 91-98.","journal-title":"Australas J Dermatol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.jaad.2022.01.048","article-title":"Association of psoriasis with risk of COVID-19: a 2-sample Mendelian randomization study","volume":"87","author":"Gu","year":"2022","unstructured":"Gu X, Chen X and Shen M. Association of psoriasis with risk of COVID-19: a 2-sample Mendelian randomization study. J Am Acad Dermatol 2022; 87: 715-717.","journal-title":"J Am Acad Dermatol"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jdin.2022.02.002","article-title":"Association between alopecia areata and COVID-19: a systematic review","volume":"7","author":"Christensen","year":"2022","unstructured":"Christensen RE and Jafferany M. Association between alopecia areata and COVID-19: a systematic review. JAAD Int 2022; 7: 57-61.","journal-title":"JAAD Int"},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"Miyazato Y, Morioka S, Tsuzuki S, Akashi M, Osanai Y, Tanaka K, Terada M, Suzuki M, Kutsuna S, Saito S, Hayakawa K and Ohmagari N. Prolonged and late-onset symptoms of coronavirus disease 2019. Open Forum Infect Dis 2020; 7: ofaa507.","DOI":"10.1093\/ofid\/ofaa507"},{"key":"ref45","doi-asserted-by":"publisher","unstructured":"Picone V, Martora F, Fabbrocini G and Marano L. “Covid arm”: abnormal side effect after Moderna COVID-19 vaccine. Dermatol Ther 2022; 35: e15197.","DOI":"10.1111\/dth.15197"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s13555-022-00689-y","article-title":"A case of new-onset Lichen Planus after COVID-19 vaccination","volume":"12","author":"Picone","year":"2022","unstructured":"Picone V, Fabbrocini G, Martora L and Martora F. A case of new-onset Lichen Planus after COVID-19 vaccination. Dermatol Ther (Heidelb) 2022; 12: 801-805.","journal-title":"Dermatol Ther (Heidelb)"}],"container-title":["American Journal of Clinical and Experimental Immunology"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajcei\/13\/3\/ajcei0155166.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:54:08Z","timestamp":1766022848000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajcei\/13\/3\/ajcei0155166.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":47,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.62347\/bduc7952","relation":{},"ISSN":["2164-7712"],"issn-type":[{"type":"electronic","value":"2164-7712"}],"subject":[],"published":{"date-parts":[[2024]]}}}